To study the impact of HP1γ invalidation on nuclear structures, we carried out the deletion of the Cbx3 gene in the colonic adenocarcinoma cell line TC7 using the CRISPR-Cas9 gene editing technique. This evidence concerns the gene CBX3 and colon adenocarcinoma.